Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sports Med Open ; 7(1): 24, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33825065

ABSTRACT

BACKGROUND: The assessment of improvement or maintenance of joint health in healthy subjects is a great challenge. The aim of the study was the evaluation of a joint stress test to assess joint discomfort in subjects with activity-related knee joint discomfort (ArJD). RESULTS: Forty-five subjects were recruited to perform the single-leg-step-down (SLSD) test (15 subjects per group). Subjects with ArJD of the knee (age 22-62 years) were compared to healthy subjects (age 24-59 years) with no knee joint discomfort during daily life sporting activity and to subjects with mild-to-moderate osteoarthritis of the knee joint (OA, Kellgren score 2-3, age 42-64 years). The subjects performed the SLSD test with two different protocols: (I) standardization for knee joint discomfort; (II) standardization for load on the knee joint. In addition, range of motion (ROM), reach test, acute pain at rest and after a single-leg squat and knee injury, and osteoarthritis outcome score (KOOS) were assessed. In OA and ArJD subjects, knee joint discomfort could be reproducibly induced in a short time interval of less than 10 min (200 steps). In healthy subjects, no pain was recorded. A clear differentiation between study groups was observed with the SLSD test (maximal step number) as well as KOOS questionnaire, ROM, and reach test. In addition, a moderate to good intra-class correlation was shown for the investigated outcomes. CONCLUSIONS: These results suggest the SLSD test is a reliable tool for the assessment of knee joint health function in ArJD and OA subjects to study the improvements in their activities. Further, this model can be used as a stress model in intervention studies to study the impact of stress on knee joint health function.

2.
Nutrients ; 12(12)2020 Nov 25.
Article in English | MEDLINE | ID: mdl-33255787

ABSTRACT

(6S)-5-Methyltetrahydrofolic acid ((6S)-5-Methyl-THF) salts and folic acid may differ in their abilities to raise plasma (6S)-5-Methyl-THF levels. We compared the area under the curve (AUC), Cmax, and Tmax of plasma (6S)-5-Methyl-THF after intakes of (6S)-5-Methyl-THF-Na salt (Arcofolin®) and folic acid. Moreover, we compared the AUCs after intakes of (6S)-5-Methyl-THF-Na and the calcium salt, (6S)-5-Methyl-THF-Ca, that were tested against folic acid in two independent studies. The study was randomized, double blind, and cross over. Twenty-four adults (12 men and 12 women) received a single oral dose of 436 µg (6S)-5-Methyl-THF-Na and an equimolar dose of folic acid (400 µg) on two kinetic days with two weeks washout period in between. The plasma concentrations of (6S)-5-Methyl-THF were measured at 9 time points between 0 and 8 h. We found that the AUC0-8 h of plasma (6S)-5-Methyl-THF (mean (SD) = 126.0 (33.6) vs. 56.0 (25.3) nmol/L*h) and Cmax (36.8 (10.8) vs. 11.1 (4.1) nmol/L) were higher after administration of (6S)-5-Methyl-THF-Na than after the administration of folic acid (p < 0.001 for both). These differences were present in men and women. Only administration of folic acid resulted in a transient increase in plasma unmetabolized folic acid (2.5 (2.0) nmol/L after 0.5 h and 4.7 (2.9) nmol/L after 1 h). Intake of (6S)-5-Methyl-THF-Na was safe. The ratios of the AUC0-8 h for (6S)-5-Methyl-THF-Na and (6S)-5-Methyl-THF-Ca to the corresponding folic acid reference group and the delta of these AUC0-8 h did not differ between the studies. In conclusion, a single oral dose of (6S)-5-Methyl-THF-Na caused higher AUC0-8 h and Cmax of plasma (6S)-5-Methyl-THF compared to folic acid. The Na- and Ca- salts of (6S)-5-Methyl-THF are not likely to differ in their pharmacokinetics. Further studies may investigate whether supplementation of the compounds for a longer time will lead to differences in circulating or intracellular/tissue folate concentrations.


Subject(s)
Folic Acid/pharmacokinetics , Tetrahydrofolates/pharmacokinetics , Adult , Area Under Curve , Cross-Over Studies , Double-Blind Method , Female , Folic Acid/blood , Humans , Male , Tetrahydrofolates/blood , Tetrahydrofolates/chemistry , Young Adult
3.
Eur J Nutr ; 57(2): 557-568, 2018 Mar.
Article in English | MEDLINE | ID: mdl-27817128

ABSTRACT

PURPOSE: The aim of this trial was to investigate the influence of a dietetic product consisting of a unique combination of L-arginine with the vitamins B6, folic acid and B12 (Telcor® Arginin plus) on endothelial dysfunction. METHODS: Subjects aged 40-65 years with mild to moderate blood pressure (BP) elevation not treated with anti-hypertensive drugs were randomly assigned to either the dietetic product (n = 40) or a matching placebo (n = 41) for 3 months with open follow-up for a further 3 months. Postprandial change in endothelial function was assessed using the validated reactive hyperaemia index (RHI) at 3 months compared to the study onset (RHI post-pre, visit 3-visit 1; ΔΔRHI). Secondary parameters included BP and plasma homocysteine concentration. RESULTS: The primary efficacy analysis revealed superiority of the nutritional intervention over placebo (p = 0.0349) in reducing the deterioration of endothelial function. While in the active group ΔΔRHI increased (0.371 ± 0.122), almost no change could be detected in the placebo group (0.031 ± 0.100), thus demonstrating a significant improvement in vascular function in the intervention group. Moreover, the intervention reduced BP and homocysteine levels. Non-serious adverse events were equally distributed in both groups, and none of the events were assessed as possibly intervention-related by the investigators. CONCLUSIONS: This trial confirmed the effective and safe use of dietary management with L-arginine in combination with B vitamins. The primary efficacy analysis demonstrated a statistically significant superiority of the combination of L-arginine with B vitamins over placebo in improving and restoring impaired endothelial function and lowering BP in patients with mild to moderate blood pressure elevation.


Subject(s)
Arginine/therapeutic use , Dietary Supplements , Endothelium, Vascular/physiopathology , Hypertension/diet therapy , Prehypertension/diet therapy , Vitamin B Complex/therapeutic use , Arginine/adverse effects , Blood Pressure , Blood Pressure Monitoring, Ambulatory , Body Mass Index , Cohort Studies , Dietary Supplements/adverse effects , Disease Progression , Double-Blind Method , Essential Hypertension/complications , Essential Hypertension/diet therapy , Essential Hypertension/physiopathology , Female , Follow-Up Studies , Humans , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/diet therapy , Hyperhomocysteinemia/physiopathology , Hypertension/complications , Hypertension/physiopathology , Male , Middle Aged , Overweight/complications , Prehypertension/complications , Prehypertension/physiopathology , Severity of Illness Index , Vascular Resistance , Vitamin B Complex/adverse effects
4.
J Acoust Soc Am ; 123(5): 2477-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18529164

ABSTRACT

This experiment investigates the effect of images of differently colored sports cars on the loudness of a simultaneously perceived car sound. Still images of a sports car, colored in red, light green, blue, and dark green, were displayed to subjects during a magnitude estimation task. The sound of an accelerating sports car was used as a stimulus. Statistical analysis suggests that the color of the visual stimulus may have a small influence on loudness judgments. The observed loudness differences are generally equivalent to a change in sound level of about 1 dB, with maximum individual differences of up to 3 dB.


Subject(s)
Automobiles , Color , Loudness Perception , Adult , Analysis of Variance , Engineering/methods , Female , Hearing , Humans , Judgment , Male , Middle Aged , Photography , Psychoacoustics , Reference Values , United Kingdom
SELECTION OF CITATIONS
SEARCH DETAIL
...